APA (7th ed.) Citation

Nazarov, V. D., Lapin, S. V., Dobronravov, V. A., Smirnov, K. A., Mayer, D. A., Muzhetskaya, T. O., & Totolian, A. A. (2018). CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists.

Chicago Style (17th ed.) Citation

Nazarov, V. D., S. V. Lapin, V. A. Dobronravov, K. A. Smirnov, D. A. Mayer, T. O. Muzhetskaya, and A. A. Totolian. CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists, 2018.

MLA (9th ed.) Citation

Nazarov, V. D., et al. CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists, 2018.